|
In this issue of the Journal, Jang and colleagues
highlight an apparent neglect of women's health issues in a cohort of
women undergoing regular haemodialysis in Victoria.1 Their
cross-sectional survey of 48 women undergoing haemodialysis in
hospitals or satellite dialysis centres contributes to the scarce
literature on reproductive health issues in women with end-stage
renal disease (ESRD). It also clearly illustrates the potential for
holistic care to be neglected when patients are managed in a highly
specialised environment.
The most startling finding of the study is the poor adherence to
accepted guidelines for cervical cancer screening and mammography:
55% of patients had not had cervical screening within the previous two
years, while 38% of those aged 50 years or over had not had
mammography within the same period. These findings are echoed in a
recent report on women undergoing haemodialysis in the United
States.2 The figures compare with
contemporary Australian screening adherence rates of 64% for
cervical screening (women aged 20-69 years)3 and 54% for mammography
(women aged 50-69 years).4 Thus, despite intense
contact of dialysis patients with the healthcare system, adherence
to screening is lower than in the general population. Results from the
survey also indicate the need to improve sexual counselling,
contraceptive advice, menopausal management and fracture
prevention among these women.
|
. . . why are nephrologists, or indeed other hospital-based specialists, not currently dealing with patients' global health issues? . . .
| |
Consideration of hormone replacement therapy (HRT) and
osteoporosis treatment is difficult in women with ESRD. As the
authors outline, HRT carries a potential risk of vascular access
thrombosis, and there are currently no evidence-based data on the
risk-benefit ratio in this group.5 Treating or preventing bone
disease in ESRD is complex, and currently limited by lack of efficacy
and side effects of the common therapeutic agents and lack of data on
agents such as bisphosphonates. Nevertheless, it is surprising that
few of the 11 postmenopausal patients with fractures could recall HRT
being discussed with them, and only one was taking this therapy.
An important question raised by this survey is "Who should be
responsible for general healthcare issues in these patients?". The
report does not say how many respondents claimed to have a general
practitioner (GP) and, if so, maintained regular contact with this
GP. However, a reason usually given by dialysis patients for not
attending a GP is that they already spend many hours at the hospital or
dialysis centre (usually about four hours, three times a week) and,
not unreasonably, expect all their health issues to be dealt with
during that contact.
Jang and colleagues conclude from their survey that hospital-based
dialysis services should include a service that deals with women's
health issues to ensure that this aspect of their routine health
management is not neglected. So, why are nephrologists, or indeed
other hospital-based specialists, not currently dealing with
patients' global health issues? Clearly, specialists are generally
aware of guidelines for women's health screening. However, it is not a
major daily focus of the already complicated care of their patients
and is more likely to be overlooked by a physician focusing on
time-consuming, dialysis-related problems. The burgeoning number
of dialysis patients combines with limited funding to compound this
problem.
In view of these real-life pressures, I suggest an alternative
approach that involves patients' GPs, whose daily practice already
encompasses women's health screening. Since 1995, the Renal Unit at
the Princess Alexandra Hospital, Brisbane, has implemented a "Renal
Care and Support Program" to consolidate links between GPs and
dialysis and transplant centres. Interaction is via a
booklet which contains a summary of the patient's active and past
problems, status of their health screening checks (such as those
raised by Jang and colleagues), list of medications, information
pages and key guidelines for care of the ESRD patient. Advances in
information technology continue to enhance these lines of
communication.
Many studies have shown that integrated management involving GPs
achieves outcomes similar to, and in some instances better than,
hospital care.6 Our program aims to address
the global health issues of patients.7 In comparison, the
model proposed by Jang seems limited. It would underutilise the
skills of primary care physicians in healthcare screening,
duplicate services available in general practice, and move these
aspects of patient care to a system and staff not resourced to deal with
them.
However, if GPs are to be significantly involved in the care of
patients with ESRD, we must consider the suitability of applying
general principles of care to these patients. This, I believe, can be
achieved by providing guidelines in specific areas where approaches
differ. For example, it is reasonable to exercise caution in
administering HRT to a patient with recurrent vascular-access
thrombosis, and some women with ESRD have such a poor prognosis that
applying general population guidelines is not appropriate. This
issue has not been addressed by Jang and colleagues.
The findings of Jang's study illuminate an increasing problem in our
contemporary healthcare system: patients who have frequent contact
with subspecialty care may have primary healthcare issues ignored.
One way of addressing this issue is a hospital-based service to deal
with women's health issues, as proposed by Jang and colleagues, while
an alternative is shared care between the specialist service and GPs.
Clearly, further consideration and research is required. The issues
raised are also likely to translate to subspecialty services other
than nephrology.
Carmel M Hawley
Director of Nephrology Princess Alexandra Hospital, Brisbane, QLD
carmel_hawleyAThealth.qld.gov.au
- Jang C, Bell RJ, White VS, et al. Women's health issues in
haemodialysis patients. Med J Aust 2001; 175: 298-301.
-
Rush H, Neugarten J, Coco M. Women's health issues in a dialysis
population. Clin Nephrol 2000; 54: 455-462.
-
Cervical screening in Australia 1997-1998. Canberra: Australian
Institute of Health and Welfare, 2000. (AIHW Cat. No. CAN 9.)
-
BreastScreen Australia achievement report 1997 and 1998.
Canberra: Australian Institute of Health and Welfare, 2000. (AIHW
Cat. No. CAN 8.)
-
Weisinger JR. Role of hormone replacement in the management of
osteoporosis in haemodialysis women: perspectives for the future.
Nephrol Dial Transplant 2000; 15 Suppl 5: 36-37.
-
Hampson J, Roberts R, Morgan D. Shared care: a review of the
literature. Fam Pract 1996; 13: 264-279.
-
Smith R, de Looze F, Kelly B, Rigby R. "Shared care". An integrated
model of service delivery for renal and renal transplant patients
[abstract]. Abstracts of the 35th Annual Scientific Meeting of the
Australian and New Zealand Society of Nephrology; 3-5 Mar, 1999;
Brisbane (QLD).
©MJA 2001
Make a
comment
Readers may print a single copy for personal use. No further
reproduction or distribution of the articles
should proceed without the permission of the publisher. For
permission, contact the
Australasian Medical Publishing Company.
Journalists are welcome to write news stories based on what they read here, but should acknowledge their source as "an article published on the Internet by The Medical Journal of Australia <http://www.mja.com.au>".
<URL: http://www.mja.com.au/>
© 2001 Medical Journal of Australia.
|